Capital Performance Advisors’s CVS Health CVS Stock Holding History

Capital Performance Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,878	Closed	-$350K	–	353
2026 Q1	$350K	Buy	4,878 +171	+4%	+$13.2K	0.02%	286
2025 Q4	$374K	Sell	4,707 -3	-0.1%	-$237	0.03%	268
2025 Q3	$355K	Buy	4,710 +1,755	+59%	+$120K	0.06%	182
2025 Q2	$204K	Sell	2,955 -1,536	-34%	-$101K	0.04%	246
2025 Q1	$304K	Buy	+4,491	New	+$269K	0.07%	155
2024 Q4	–	Sell	-1,580	Closed	-$99.3K	–	782
2024 Q3	$99.3K	Buy	+1,580	New	+$92.2K	0.03%	198

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital Performance Advisors's CVS Position: Q2 2026 in Review

Capital Performance Advisors sold out of CVS Health (CVS) in Q2 2026, closing a stake of 4,878 shares — an estimated $350K sold.

Capital Performance Advisors first reported a position in CVS in Q3 2024 and held it in 6 quarters. The position peaked at $374K in Q4 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Capital Performance Advisors reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Capital Performance Advisors sold 4,878 CVS Health shares in Q2 2026, an estimated $350K.
Capital Performance Advisors first reported a position in CVS Health in Q3 2024 and held it in 6 quarters.
Capital Performance Advisors's CVS Health position peaked at $374K in Q4 2025.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.